The average survival for enlarged heart failure grade IV is about one year, but it can mostly be prolonged with aggressive treatment. Common treatments include pharmacologic and non-pharmacologic treatments.
1. Drug therapy: common anti-heart failure drugs include diuretics (e.g., hydrochlorothiazide), beta-blockers (e.g., propranolol), angiotensin-converting enzyme inhibitors (e.g., captopril), positive inotropic agents (e.g., digitalis), and ARNIs such as sakubutravir valsartan. Specific medications should be used as directed by a physician.
2. Non-pharmacological treatment: Some patients with heart failure have right and left ventricular contraction asynchrony, which further leads to reduced myocardial contractility and should be treated with cardiac resynchronization. Heart transplantation is the ultimate treatment for refractory heart failure.
If heart failure occurs, one should be admitted to the hospital and treated under the supervision of a physician to protect the heart and slow down the disease process.